A. Tonutti
30 Papers
1 Citations
A. Tonutti is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Anti-MDA5 Antibody Linking COVID-19, Type I Interferon, and Autoimmunity: A Case Report and Systematic Literature Review
TL;DR: It is speculated that the strong type I IFN response observed in patients with anti-MDA5 syndrome, might harbor protective effects against viral infections, including COVID-19.
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases
Maria De Santis,Francesca Motta,Natasa Isailovic,Massimo Clementi,Elena Criscuolo,Nicola Clementi,A. Tonutti,Stefano Rodolfi,Elisa Barone,F Colapietro,Angela Ceribelli,Matteo Vecellio,Nicoletta Luciano,Giacomo Maria Guidelli,Marta Caprioli,Clara Rezk,Lorenzo Maria Canziani,Elena Azzolini,Luca Germagnoli,Nicasio Mancini,Ana Lleo,Carlo Selmi +21 more
TL;DR: Mycophenolate treatment affects the Moderna-1273 mRNA vaccine immunogenicity in a dose-dependent manner, independent of rheumatological disease and the cytotoxic activity elicited by viral peptides was also impaired.
Perspectives on Mycophenolate Mofetil in the Management of Autoimmunity
TL;DR: Mechanistic data on fibroblasts may in the future allow to reevaluate the use of MMF in selected patients with inflammatory arthritis or systemic sclerosis, and attention must be paid towards the possible occurrence of adverse events, such as gastrointestinal complaints and teratogenicity.
13
Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review
Anna Stainer,A. Tonutti,Maria De Santis,Francesco Amati,Angela Ceribelli,Gabriele Bongiovanni,C. Torrisi,Antonio Iacopino,Giuseppe Mangiameli,Stefano Aliberti,Carlo Selmi +10 more
TL;DR: In this paper , the authors proposed that a better understanding of the mechanisms connecting RA with ILD in a subgroup of patients as well as the creation of adequate diagnostic pathways will be mandatory steps for a more effective management of this clinically challenging entity.
Interstitial lung disease associated with inflammatory myositis: Autoantibodies, clinical phenotypes, and progressive fibrosis
TL;DR: In this article , the authors provided a narrative review of the literature and also presented original data on pulmonary fibrosis in a cohort of patients with myositis and serum anti-Ro52 with interstitial lung disease.